Literature DB >> 13539104

Osteopetrosis with syndactyly; a morphological variant of Albers-Schönberg's disease.

A S TRUSWELL.   

Abstract

Entities:  

Keywords:  FINGERS AND TOES/abnormalities; OSTEOPETROSIS/case reports

Mesh：

Year:  1958        PMID： 13539104

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN： 0301-620X


× No keyword cloud information.
  20 in total

1.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 2.  Sclerostin and skeletal health.

Authors:  Maryam Sharifi; Lisa Ereifej; E Michael Lewiecki
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

Review 3.  Sclerosing bone dysplasias--a target-site approach.

Authors:  A Greenspan
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

Review 4.  The osteocyte plays multiple roles in bone remodeling and mineral homeostasis.

Authors:  Huayue Chen; Takao Senda; Kin-ya Kubo
Journal:  Med Mol Morphol       Date:  2015-03-20       Impact factor: 2.309

Review 5.  A review of osteocyte function and the emerging importance of sclerostin.

Authors:  Jocelyn T Compton; Francis Y Lee
Journal:  J Bone Joint Surg Am       Date:  2014-10-01       Impact factor: 5.284

6.  Amgen/UCB build on bone franchise with anti-sclerostin antibody.

Authors:  Suzanne Elvidge
Journal:  Nat Biotechnol       Date:  2016-06-09       Impact factor: 54.908

Review 7.  Craniotubular bone disorders.

Authors:  R J Gorlin
Journal:  Pediatr Radiol       Date:  1994

Review 8.  Sclerostin: therapeutic horizons based upon its actions.

Authors:  Aline G Costa; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

Review 9.  Sclerostin: from bench to bedside.

Authors:  Sakae Tanaka; Toshio Matsumoto
Journal:  J Bone Miner Metab       Date:  2020-11-18       Impact factor: 2.626

10.  Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.

Authors:  Cristina Remoli; Stefano Michienzi; Benedetto Sacchetti; Alberto Di Consiglio; Stefania Cersosimo; Emanuela Spica; Pamela G Robey; Kenn Holmbeck; Ana Cumano; Alan Boyde; Graham Davis; Isabella Saggio; Mara Riminucci; Paolo Bianco
Journal:  J Bone Miner Res       Date:  2015-06       Impact factor: 6.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.